Andrèn O, Garmo H, Mucci L, Andersson S-O, Johansson J-E, Fall K
Department of Urology Orebro University Hospital, Orebro 701 85, Sweden.
Br J Cancer. 2009 Jan 13;100(1):170-3. doi: 10.1038/sj.bjc.6604834. Epub 2008 Dec 16.
In a national register-based study of incidence trends and mortality of incidental prostate cancer in Sweden, we found that a significant proportion (26.6%) of affected men diagnosed died of their disease, which challenges earlier descriptions of incidental prostate cancer as a non-lethal disease.
在一项基于瑞典国家登记册的关于偶发性前列腺癌发病率趋势和死亡率的研究中,我们发现,确诊的患病男性中有很大一部分(26.6%)死于该疾病,这对早期将偶发性前列腺癌描述为非致命性疾病的观点提出了挑战。